Regeneron convinces PTAB to review Novartis syringe patent

28-10-2021

Alex Baldwin

Regeneron convinces PTAB to review Novartis syringe patent

Formatoriginal / Shutterstock.com

The US Patent Trial and Appeal Board (PTAB) has granted a review of a Novartis syringe patent following a challenge from biotech giant Regeneron.


Regeneron, PTAB, Novartis, Syringe, patent, ITC, International, Trade, Commission

More on this story

PTAB grants IPR of Regeneron Eylea patents
11-11-2021

LSIPR